BioHealth News Archive

LumaCyte Awarded Frost & Sullivan 2019 Global Single-Cell Analysis New Product Innovation Award for Its Novel Laser Force Cytology™ Technology

LumaCyte Awarded Frost & Sullivan 2019 Global Single-Cell Analysis New Product Innovation Award for Its Novel Laser Force Cytology™ Technology

SANTA CLARA, Calif., Jan. 7, 2020 /PRNewswire/ -- Based on its recent analysis of the global single-cell analysis market, Frost & Sullivan recognizes LumaCyte, LLC…

Read More
NexImmune Expands Executive Team with Appointments of Chief Medical Officer and Chief Financial Officer

NexImmune Expands Executive Team with Appointments of Chief Medical Officer and Chief Financial Officer

GAITHERSBURG, Md., Jan. 09, 2020 (GLOBE NEWSWIRE) -- NexImmune, a clinical-stage biopharmaceutical company developing novel immune-therapeutics based on a proprietary Artificial Immune Modulation (AIM)…

Read More
Laboratory Space Available

Laboratory Space Available

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® REIT, is the first and longest-tenured owner, operator, and developer uniquely focused on collaborative life…

Read More
UMB, JHU Collaborate to Advance Drug Discovery – University of Maryland, Baltimore

UMB, JHU Collaborate to Advance Drug Discovery – University of Maryland, Baltimore

The University of Maryland School of Pharmacy welcomed nearly 200 researchers from across the University of Maryland, Baltimore (UMB) and Johns Hopkins University (JHU)…

Read More
GlycoMimetics and Apollomics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Uproleselan and GMI-1687 in Greater China – GlycoMimetics, Inc.

GlycoMimetics and Apollomics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Uproleselan and GMI-1687 in Greater China – GlycoMimetics, Inc.

ROCKVILLE, Md. & FOSTER CITY, Calif. & HANGZHOU, China--(BUSINESS WIRE)--Jan. 6, 2020-- GlycoMimetics, Inc. (NASDAQ: GLYC), a leader in the field of applied glycotechnology…

Read More
Biotech, life sciences incubator opens in Manhattan | Real Estate Weekly

Biotech, life sciences incubator opens in Manhattan | Real Estate Weekly

The largest biotechnology incubator of its kind in New York City has opened at 180 Varick Street in Hudson Square. BioLabs @ NYULangone is…

Read More
(New Year Special) Investors vulnerable to risky biotech business – Korea Biomedical Review

(New Year Special) Investors vulnerable to risky biotech business – Korea Biomedical Review

President Moon Jae-in announced in May that the government would designate the biohealth industry as one of the three new sectors for future growth,…

Read More
New Theory For Cancer Immunotherapy – University of Maryland, Baltimore

New Theory For Cancer Immunotherapy – University of Maryland, Baltimore

Scientists from the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) this week proposed a new theory, based on…

Read More
TEDCO, NIST give four companies funding – Maryland Daily Record

TEDCO, NIST give four companies funding – Maryland Daily Record

The Maryland Technology Development Corp. and the National Institute of Standards and Technology awarded four companies a total of $448,000 to develop NIST-licensed technologies…

Read More
TEDCO is ready to invest again, Maryland Venture Fund remains on hold – Baltimore Business Journal

TEDCO is ready to invest again, Maryland Venture Fund remains on hold – Baltimore Business Journal

Eight months after Maryland Technology Development Corp. halted investments through some of its funds, the state-backed organization announced Friday it is ready to accept…

Read More
Research Hailed for Making the World a Better Place – University of Maryland, Baltimore

Research Hailed for Making the World a Better Place – University of Maryland, Baltimore

The University of Maryland School of Medicine is being recognized by a national news publication for groundbreaking biomedical research that “is making the world…

Read More
Intrexon To Achieve $175M Cash Goal, Appoints Helen Sabzevari, PhD, As New President And CEO And Will Change Name To Precigen To Reflect Healthcare Focus

Intrexon To Achieve $175M Cash Goal, Appoints Helen Sabzevari, PhD, As New President And CEO And Will Change Name To Precigen To Reflect Healthcare Focus

GERMANTOWN, Md., Jan. 2, 2020 /PRNewswire/ -- Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality…

Read More
The Top 25 Women Leaders In Biotech of 2019 | The Healthcare Technology Report.

The Top 25 Women Leaders In Biotech of 2019 | The Healthcare Technology Report.

The Healthcare Technology Report is pleased to announce and recognize a unique set of accomplished women playing vital roles in some of the most…

Read More
Applications Now Open for TEDCO’s Investment Funds | TEDCO

Applications Now Open for TEDCO’s Investment Funds | TEDCO

COLUMBIA, Md. (January 3, 2020)—TEDCO, Maryland’s economic engine for technology companies, announced today that its programs: Rural Business Innovation Initiative (RBII Fund), Builder Fund…

Read More
2019’s Top 10 Most Read Biotech News Stories from the BioHealth Capital Region · BioBuzz

2019’s Top 10 Most Read Biotech News Stories from the BioHealth Capital Region · BioBuzz

2019 was an eventful year in the BioHealth Capital Region (BHCR), to say the least, and BioBuzz has been there to document it every…

Read More